Macrophage migration inhibitory factor has a MHC class I-like motif and function

Scandinavian Journal of Immunology

Volumn 67, Issue 2, 2008, Pages 121-132

  Gibbings, D J ^a   Ghetu, A F ^b   Dery, R ^a   Befus, A D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MACROPHAGE MIGRATION INHIBITION FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; IMMUNOAFFINITY CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; RAT;

AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; EPITOPE MAPPING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KILLER CELLS, LYMPHOKINE-ACTIVATED; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RATS;

EID: 38149042590     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02046.x     Document Type: Article

References (76)

1. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003 3 : 791 800.
2. Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993 365 : 756 9.
3. Vitale C, Chiossone L, Cantoni C et al. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol 2004 34 : 3028 38.
4. Gatti G, Masera RG, Pallavicini L et al. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Brain Behav Immun 1993 7 : 16 28.
5. Arcuri F, Ricci C, Ietta F et al. Macrophage migration inhibitory factor in the human endometrium: expression and localization during the menstrual cycle and early pregnancy. Biol Reprod 2001 64 : 1200 5.
6. Arcuri F, Cintorino M, Vatti R, Carducci A, Liberatori S, Paulesu L. Expression of macrophage migration inhibitory factor transcript and protein by first-trimester human trophoblasts. Biol Reprod 1999 60 : 1299 303.
7. Yamada H, Kato EH, Morikawa M et al. Decreased serum levels of macrophage migration inhibition factor in miscarriages with normal chromosome karyotype. Hum Reprod 2003 18 : 616 20.
8. Arcuri F, Cintorino M, Carducci A et al. Human decidual natural killer cells as a source and target of macrophage migration inhibitory factor. Reproduction 2006 131 : 175 82.
9. Repp AC, Mayhew ES, Apte S, Niederkorn JY. Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 2000 165 : 710 5.
10. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY. Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 1998 160 : 5693 6.
11. Abe R, Peng T, Sailors J, Bucala R, Metz CN. Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 2001 166 : 747 53.
12. Mitchell RA. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 2004 16 : 13 9.
13. Leng L, Metz CN, Fang Y et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003 197 : 1467 76.
14. Liu DY, Yu SF, Remold HG, David JR. Glycolipid receptor for human migration inhibitory factor: fucose and sialic acid are important for the human monocyte response to migration inhibitory factor. Cell Immunol 1985 90 : 539 46.
15. Liu DY, Yu SF, Remold HG, David JR. Macrophage glycolipid receptors for human migration inhibitory factor (MIF): differentiated HL-60 cells exhibit MIF responsiveness and express surface glycolipids which both bind MIF and convert nonresponsive cells to responsiveness. Cell Immunol 1985 90 : 605 13.
16. Liu DY, Petschek KD, Remold HG, David JR. Isolation of a guinea pig macrophage glycolipid with the properties of the putative migration inhibitory factor receptor. J Biol Chem 1982 257 : 159 62.
17. Poste G, Allen H, Matta KL. Cell surface receptors for lymphokines. II. Studies on the carbohydrate composition of the MIF receptor on macrophages using synthetic saccharides and plant lectins. Cell Immunol 1979 44 : 89 98.
18. Kleemann R, Hausser A, Geiger G et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000 408 : 211 6.
19. Watanabe H, Shimizu T, Nishihira J et al. Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J Biol Chem 2004 279 : 1676 83.
20. Kleemann R, Mischke R, Kapurniotu A, Brunner H, Bernhagen J. Specific reduction of insulin disulfides by macrophage migration inhibitory factor (MIF) with glutathione and dihydrolipoamide: potential role in cellular redox processes. FEBS Lett 1998 430 : 191 6.
21. Kleemann R, Kapurniotu A, Frank RW et al. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 1998 280 : 85 102.
22. Cerwenka A, Bakker AB, McClanahan T et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 2000 12 : 721 7.
23. Lodoen MB, Abenes G, Umamoto S, Houchins JP, Liu F, Lanier LL. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 2004 200 : 1075 81.
24. Leong CC, Chapman TL, Bjorkman PJ et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 1998 187 : 1681 7.
25. Li P, Willie ST, Bauer S, Morris DL, Spies T, Strong RK. Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity 1999 10 : 577 84.
26. Zou Z, Nomura M, Takihara Y, Yasunaga T, Shimada K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules. J Biochem (Tokyo) 1996 119 : 319 28.
27. Lanier LL. NK cell recognition. Annu Rev Immunol 2005 23 : 225 74.
28. Leong LY, Le Rolle AF, Deverson EV et al. RT1-U: identification of a novel, active, class Ib alloantigen of the rat MHC. J Immunol 1999 162 : 743 52.
29. Lambracht-Washington D, Duvel H, Hanisch L, Dinkel A, Wonigeit K. RT1.L: a family of MHC class Ib genes of the rat major histocompatibility complex with a distinct promoter structure. Immunogenetics 2004 56 : 28 37.
30. Spencer SC, Fabre JW. Identification in rat liver and serum of water-soluble class I MHC molecules possibly homologous to the murine Q10 gene product. J Exp Med 1987 165 : 1595 608.
31. Bradley MP, Baird MA, Heslop BF. An immunochemical procedure for the purification of rat class I antigens (RT1.A/RT1.E) from detergent-solubilized erythrocytes. Anal Biochem 1987 160 : 169 77.
32. Jameson SC, Tope WD, Tredgett EM, Windle JM, Diamond AG, Howard JC. Cloning and expression of class I major histocompatibility complex genes of the rat. J Exp Med 1992 175 : 1749 57.
33. Bernhard OK, Cunningham AL, Sheil MM. Analysis of proteins copurifying with the CD4/lck complex using one-dimensional polyacrylamide gel electrophoresis and mass spectrometry: comparison with affinity-tag based protein detection and evaluation of different solubilization methods. J Am Soc Mass Spectrom 2004 15 : 558 67.
34. Lau P, Amadou C, Brun H et al. Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites. BMC Immunol 2003 4 : 7.
35. Joly E, Leong L, Coadwell WJ, Clarkson C, Butcher GW. The rat MHC haplotype RT1c expresses two classical class I molecules. J Immunol 1996 157 : 1551 8.
36. Salgar SK, Kunz HW, Gill TJ III. Nucleotide sequence and structural analysis of the rat RT1.Eu and RT1.Aw3l genes, and of genes related to RT1.O and RT1.C. Immunogenetics 1995 42 : 244 53.
37. Rothermel E, Heine L, Wurst W, Gunther E. Characterization of a class Ib gene of the rat major histocompatibility complex. Immunogenetics 1993 38 : 82 91.
38. Smits KM, Kuppen PJ, Eggermont AM, Tamatani T, Miyasaka M, Fleuren GJ. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells. Eur J Immunol 1994 24 : 171 5.
39. Osawa H, Herrmann T, Diamantstein T. Inhibition of IL 2-dependent proliferation of rat T lymphoblasts by the monoclonal antibody ART62 which reacts with MHC class 1 antigens. J Immunol 1985 134 : 3901 6.
40. Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 2003 4 : 913 9.
41. Takai T. Paired immunoglobulin-like receptors and their MHC class I recognition. Immunology 2005 115 : 433 40.
42. Nakamura A, Kobayashi E, Takai T. Exacerbated graft-versus-host disease in Pirb-/- mice. Nat Immunol 2004 5 : 623 9.
43. Rolleke U, Flugge G, Plehm S et al. Differential expression of major histocompatibility complex class I molecules in the brain of a New World monkey, the common marmoset (Callithrix jacchus). J Neuroimmunol 2006 176 : 39 50.
44. Dimasi N, Biassoni R. Structural and functional aspects of the Ly49 natural killer cell receptors. Immunol Cell Biol 2005 83 : 1 8.
45. Kern PS, Teng MK, Smolyar A et al. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb. Immunity 1998 9 : 519 30.
46. Kleemann R, Grell M, Mischke R, Zimmermann G, Bernhagen J. Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives. J Interferon Cytokine Res 2002 22 : 351 63.
47. Michaelsson J, Achour A, Salcedo M et al. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol 2000 30 : 300 7.
48. Chen H, Centola M, Altschul SF, Metzger H. Characterization of gene expression in resting and activated mast cells. J Exp Med 1998 188 : 1657 68.
49. Zhang H, Meng F, Chu CL, Takai T, Lowell CA. The Src family kinases Hck and Fgr negatively regulate neutrophil and dendritic cell chemokine signaling via PIR-B. Immunity 2005 22 : 235 46.
50. Yamauchi A, Bloom ET. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells. J Immunol 1993 151 : 5535 44.
51. Ting CC, Hargrove ME, Liang SM, Liang CM, Sharrow SO. Dichotomy of glutathione regulation of the activation of resting and preactivated lymphocytes. Cell Immunol 1992 142 : 40 53.
52. Trotta R, Fettucciari K, Azzoni L et al. Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity. J Immunol 2000 165 : 1782 9.
53. Chagnon F, Metz CN, Bucala R, Lesur O. Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization. Circ Res 2005 96 : 1095 102.
54. Cvetkovic I, Al Abed Y, Miljkovic D et al. Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes. Endocrinology 2005 146 : 2942 51.
55. Ichiyama H, Onodera S, Nishihira J et al. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 2004 26 : 187 94.
56. Calandra T, Echtenacher B, Roy DL et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000 6 : 164 70.
57. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001 15 : 897 908.
58. Vigna JL, Smith KD, Lutz CT. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove. J Immunol 1996 157 : 4503 10.
59. Sugita M, Brenner MB. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J Biol Chem 1995 270 : 1443 8.
60. Cerundolo V, Elliott T, Elvin J, Bastin J, Townsend A. Association of the human invariant chain with H-2 Db class I molecules. Eur J Immunol 1992 22 : 2243 8.
61. Hoelsbrekken SE, Fossum S, Dissen E. Molecular cloning of LILRC1 and LILRC2 in the mouse and the rat, two novel immunoglobulin-like receptors encoded by the leukocyte receptor gene complex. Immunogenetics 2005 57 : 1 8.
62. Dam J, Guan R, Natarajan K et al. Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol 2003 4 : 1213 22.
63. Matsumoto N, Mitsuki M, Tajima K, Yokoyama WM, Yamamoto K. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J Exp Med 2001 193 : 147 58.
64. Tormo J, Natarajan K, Margulies DH, Mariuzza RA. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 1999 402 : 623 31.
65. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995 2 : 439 49.
66. Borges L, Cosman D. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev 2000 11 : 209 17.
67. Willcox BE, Thomas LM, Chapman TL, Heikema AP, West AP Jr., Bjorkman PJ. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18. BMC Struct Biol 2002 2 : 6.
68. Shiroishi M, Tsumoto K, Amano K et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 2003 100 : 8856 61.
69. Dennis G Jr., Stephan RP, Kubagawa H, Cooper MD. Characterization of paired Ig-like receptors in rats. J Immunol 1999 163 : 6371 7.
70. Kubagawa H, Chen CC, Ho LH et al. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med 1999 189 : 309 18.
71. Yamashita Y, Fukuta D, Tsuji A et al. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family. J Biochem (Tokyo) 1998 123 : 358 68.
72. Bernard K, Cambiaggi A, Guia S et al. Engagement of natural cytotoxicity programs regulates AP-1 expression in the NKL human NK cell line. J Immunol 1999 162 : 4062 8.
73. Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. J Exp Med 2003 197 : 437 49.
74. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994 22 : 4673 80.
75. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res 1988 16 : 10881 90.
76. Gibbings DJ, Marcet-Palacios M, Sekar Y, Ng MC, Befus AD. CD8alpha is expressed by human monocytes and enhances FcgammaR-dependent responses. BMC Immunol 2007 8 : 12.